Christina Michelle Engert, NP

Christina Engert practices at Mercy Clinic Gastroenterology - Primary Care - Saint Louis (Kennerly Rd) in Saint Louis, Missouri.

Christina Engert's NPI, 1861142473, was assigned on March 25, 2022. Christina Engert holds Missouri license 2022010991.

Christina Engert's primary practice is Mercy Clinic Gastroenterology - Primary Care - Saint Louis (Kennerly Rd), at 10012 Kennerly Rd Ste 102 Suite 102, Saint Louis, MO 63128. The practice phone is (314) 543-5911. The NPI Registry lists Christina Engert's practice address as 10010 Kennerly Rd, Saint Louis, MO 63128.

Christina Engert's primary practice is Mercy Clinic Gastroenterology - Primary Care - Saint Louis (Kennerly Rd) in Saint Louis, Missouri. Christina Engert is also affiliated with Mercy Hospital South. The medical group on file is Mercy Clinic Gastroenterology. Dmand AI also links Christina Engert to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christina Engert practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Christina Engert's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Christina Engert is licensed in Missouri.

CMS counts 115 Medicare patients who saw Christina Engert in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christina Engert's median patient age at 74, with 60% women.

In 2024, Christina Engert wrote 60 Medicare Part D claims for 24 patients. 27% of them were for generic drugs.

Christina Engert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christina Engert as offering telehealth.

CMS Open Payments shows 13 general payments to Christina Engert from 9 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $105.